Activation of the adenosine A1 receptor inhibits HIV-1 Tat-induced apoptosis by reducing nuclear factor-κB activation and inducible nitric-oxide synthase

Molecular Pharmacology

Volumn 72, Issue 4, 2007, Pages 856-867

  Pingle, Sandeep C ^b   Jajoo, Sarvesh ^a   Mukherjea, Debashree ^a   Sniderhan, Lynn F ^c   Jhaveri, Krishna A ^a   Marcuzzi, Adriana ^a   Rybak, Leonard P ^a   Maggirwar, Sanjay B ^c   Ramkumar, Vickram ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE A1 RECEPTOR; CALCIUM ION; CASPASE 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LUCIFERASE; N(G) NITROARGININE METHYL ESTER; NEUROTOXIN; NITRIC OXIDE; PROTEIN BAX; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; ASTROCYTE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DEMENTIA; FLOW CYTOMETRY; GEL MOBILITY SHIFT ASSAY; GENETIC TRANSFECTION; GRANULE CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOHISTOCHEMISTRY; LIGAND BINDING; MACROGLIA; MEDIATOR RELEASE; NERVE CELL LESION; NICK END LABELING; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; WESTERN BLOTTING; ANIMAL; CELL STRAIN; CYTOLOGY; DRUG POTENTIATION; ENZYME ACTIVATION; METABOLISM; NERVE CELL; PHYSIOLOGY;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME ACTIVATION; GENE PRODUCTS, TAT; HIV-1; IMMUNOHISTOCHEMISTRY; NEURONS; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; PC12 CELLS; RATS; RECEPTOR, ADENOSINE A1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 34748877183     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.106.031427     Document Type: Article

References (50)

1. Adamson DC, Wildemann B, Sasaki M, Glass JD, McArthur JC, Christov VI, Dawson TM, and Dawson VL (1996) Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41. Science 274:1917-1921.
2. Bachis A and Mocchetti I (2004) The chemokine receptor CXCR4 and not the N-methyl-D aspartate receptor mediates gp120 neurotoxicity in cerebellar granule cells. J Neurosci Res 75:75-82.
3. Bartz SR and Emerman M(1999) Human immunodeficiency virus type 1 Tat induces apoptosis and increases sensitivity to apoptotic signals by up-regulating FLICE/caspase-8. J Virol 73:1956-1963.
4. Boison D (2005) Adenosine and epilepsy: from therapeutic rationale to new therapeutic strategies. Neuroscientist 11:25-36.
5. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
6. Brewer GJ, Torricelli JR, Evege EK, and Price PJ (1993) Optimized survival of hippocampal neurons in B27-supplemented Neurobasal, a new serum-free medium combination. J Neurosci Res 35:567-576.
7. Burdo TH, Gartner S, Mauger D, and Wigdahl B (2004) Region-specific distribution of human immunodeficiency virus type 1 long terminal repeats containing specific configurations of CCAAT/enhancer-binding protein site II in brains derived from demented and nondemented patients. J Neurovirol 10:7-14.
8. Canafoglia L, Panzica F, Franceschetti S, Carriero MR, Ciano C, Scaioli V, Chiapparini L, Visani E, and Avanzini G (2003) Rhythmic cortical myoclonus in a case of HIV-related encephalopathy. Mov Disord 18:1533-1538.
9. Chen YJ, Hsu KW, Tsai JN, Hung CH, Kuo TC, and Chen YL (2005) Involvement of protein kinase C in the inhibition of lipopolysaccharide-induced nitric oxide production by thapsigargin in RAW 264.7 macrophages. Int J Biochem Cell Biol 37:2574-2585.
10. Cho IJ, Lee AK, Lee SJ, Lee MG, and Kim SG (2005) Repression by oxidative stress of iNOS and cytokine gene induction in macrophages results from AP-1 and NF-kappaB inhibition mediated by B cell translocation gene-1 activation. Free Rad Biol Med 39:1523-1536.
11. Conant K, Ma M, Nath A, and Major EO (1996) Extracellular human immunodeficiency virus type 1 Tat protein is associated with an increase in both NF-kappa B binding and protein kinase C activity in primary human astrocytes. J Virol 70:1384-1389.
12. Dunwiddie TV and Masino SA (2001) The role and regulation of adenosine in the central nervous system. Annu Rev Neurosci 24:31-55.
13. Everall IP, Hudson L, al-Sarraj S, Honavar M, Lantos P, and Kerwin R (1995) Decreased expression of AMPA receptor messenger RNA and protein in AIDS: a model for HIV associated neurotoxicity. Nat Med 1:1174-1178.
14. Faure M, Voyno-Yasenetskaya TA, and Bourne HR (1994) cAMP and βγ subunits of heterotrimeric G proteins stimulate the mitogen-activated protein kinase pathway in COS-7 cells. J Biol Chem 269:7851-7854.
15. Fotheringham J, Mayne M, Holden C, Nath A, and Geiger JD (2004) Adenosine receptors control HIV-1 Tat-induced inflammatory responses through protein phosphatase. Virology 327:186-195.
16. Gavriil ES, Cooney R, and Weeks BS (2000) Tat mediates apoptosis in vivo in the rat central nervous system. Biochem Biophys Res Commun 267:252-256.
17. González-Scarano F, and Martin-Garcia J (2005) The neuropathogenesis of AIDS. Nat Rev Immunol 5:69-81.
18. Guroff G, Dickens G, End D, and Londos C (1981) The action of adenosine analogs on PC12 cells. J Neurochem 37:1431-1439.
19. Haughey NJ, Holden CP, Nath A, and Geiger JD (1999) Involvement of inositol 1,4,5 trisphosphate-regulated stores of intracellular calcium in calcium dysregulation and neuron cell death caused by HIV-1 protein tat. J Neurochem 73:1363-1374.
20. Jaffrey SR and Snyder SH (1995) Nitric oxide: a neural messenger. Annu Rev Cell Dev Biol 11:417-440.
21. Jajoo S, Mukherjea D, Pingle S, Sekino Y, and Ramkumar V (2006) Induction of adenosine A1 receptor expression by pertussis toxin via an adenosine 5′-diphosphate ribosylation independent pathway. J Pharmacol Exp Ther 317:1-10.
22. Jones M, Olafson K, Del Bigio MR, Peeling J, and Nath A (1998) Intraventricular injection of human immunodeficiency virus type 1 (HIV-1) tat protein causes inflammation, gliosis, apoptosis, and ventricular enlargement. J Neuropathol Exp Neurol 57:563-570.
23. Kaul M, Garden GA, and Lipton SA (2001) Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 410:988-994.
24. Kruman II, Nath A, and Mattson MP (1998) HIV-1 protein Tat induces apoptosis of hippocampal neurons by a mechanism involving caspase activation, calcium overload, and oxidative stress. Exp Neurol 154:276-288.
25. Kumar A, Manna SK, Dhawan S, and Aggarwal BB (1998) HIV-Tat protein activates c-Jun N-terminal kinase and activator protein-1. J Immunol 161:776-781.
26. Langford D, Grigorian A, Hurford R, Adame A, Crews L, and Masliah E (2004) The role of mitochondrial alterations in the combined toxic effects of human immunodeficiency virus Tat protein and methamphetamine on calbindin positive-neurons. J Neurovirol 10:327-337.
27. Liu Y, Sato T, O'Rourke B, and Marban E (1998) Mitochondrial ATP-dependent potassium channels: novel effectors of cardioprotection? Circulation 97:2463-2469.
28. 3 receptor in RAW 264.7 cells inhibits lipopolysaccharide-stimulated tumor necrosis factor-alpha release by reducing calcium-dependent activation of nuclear factor κB and extracellular signal-regulated kinase 1/2. J Pharmacol Exp Ther 316:71-78.
29. Moncada S, Palmer RM, and Higgs EA (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109-142.
30. Nath A, Haughey NJ, Jones M, Anderson C, Bell JE, and Geiger JD (2000) Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: protection by memantine. Ann Neurol 47:186-194.
31. 2A adenosine receptors in PC12 cells. Mol Pharmacol 56:947-954.
32. New DR, Maggirwar SB, Epstein LG, Dewhurst S, and Gelbard HA (1998) HIV-1 Tat induces neuronal death via tumor necrosis factor-α and activation of non-N-methyl D-aspartate receptors by a NFκB-independent mechanism. J Biol Chem 273:17852-17858.
33. Ochiishi T, Chen L, Yukawa A, Saitoh Y, Sekino Y, Arai T, Nakata H, and Miyamoto H (1999) Cellular localization of adenosine A1 receptors in rat forebrain: immunohistochemical analysis using adenosine A1 receptor-specific monoclonal antibody. J Comp Neurol 411:301-316.
34. Pingle SC, Mishra S, Marcuzzi A, Bhat SG, Sekino Y, Rybak LP, and Ramkumar V (2004) Osmotic diuretics induce adenosine A1 receptor expression and protect renal proximal tubular epithelial cells against cisplatin-mediated apoptosis. J Biol Chem 279:43157 43167.
35. Pingle SC, Sanchez JF, Hallam DM, Williamson AL, Maggirwar SB, and Ramkumar V (2003) Hypertonicity inhibits lipopolysaccharide-induced nitric oxide synthase expression in smooth muscle cells by inhibiting nuclear factor κB. Mol Pharmacol 63:1238-1247.
36. Ramirez SH, Sanchez JF, Dimitri CA, Gelbard HA, Dewhurst S, and Maggirwar SB (2001) Neurotrophins prevent HIV Tat-induced neuronal apoptosis via a nuclear factor-kappa B (NF-κB)-dependent mechanism. J Neurochem 78:874-889.
37. Ramkumar V, Hallam DM, and Nie Z (2001) Adenosine, oxidative stress and cytoprotection. Jpn J Pharmacol 86:265-274.
38. Reed JC (1997) Double identity for proteins of the Bcl-2 family. Nature 387:773-776.
39. Ren H and Stiles GL (1995) Separate promoters in the human A1 adenosine receptor gene direct the synthesis of distinct messenger RNAs that regulate receptor abundance. Mol Pharmacol 48:975-980.
40. Rizzi C, Alfano M, Bugatti A, Camozzi M, Poli G, and Rusnati M (2004) Inhibition of intra- and extra-cellular Tat function and HIV expression by pertussis toxin B-oligomer. Eur J Immunol 34:530-536.
41. 1MF-2 cells. Eur J Pharmacol 413:151-161.
42. Rubio R, Berne RM, Bockman EL, and Curnish RR (1975) Relationship between adenosine concentration and oxygen supply in rat brain. Am J Physiol 228:1896-1902.
43. Schwarze SR, Ho A, Vocero-Akbani A, and Dowdy SF (1999) In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 285:1569-1572.
44. Shou Y, Li N, Li L, Borowitz JL, and Isom GE (2002) NF-kappaB-mediated up-regulation of Bcl-X(S) and Bax contributes to cytochrome c release in cyanide-induced apoptosis. J Neurochem 81:842-852.
45. Sui Z, Kovacs AD, and Maggirwar SB (2006) Recruitment of active glycogen synthase kinase-3 into neuronal lipid rafts. Biochem Biophys Res Commun 345:1643-1648.
46. Vicente S, Perez-Rodriguez R, Olivan AM, Martinez Palacian A, Gonzalez MP, and Oset Gasque MJ (2006) Nitric oxide and peroxynitrite induce cellular death in bovine chromaffin cells: evidence for a mixed necrotic and apoptotic mechanism with caspases activation. J Neurosci Res 84:78-96.
47. Wong K, Sharma A, Awasthi S, Matlock EF, Rogers L, Van Lint C, Skiest DJ, Burns DK, and Harrod R (2005) HIV-1 Tat interactions with p300 and PCAF transcriptional coactivators inhibit histone acetylation and neurotrophin signaling through CREB. J Biol Chem 280:9390-9399.
48. 1 receptor antagonist and mitochondrial ATP sensitive potassium channel blocker attenuate the tolerance to focal cerebral ischemia in rats. J Cereb Blood Flow Metab 24:771-779.
49. Zocchi MR, Contini P, Alfano M, and Poggi A (2005) Pertussis toxin (PTX) B subunit and the nontoxic PTX mutant PT9K/129G inhibit tat-induced TGF-β production by NK cells and TGF-β-mediated NK cell apoptosis. J Immunol 174:6054-6061.
50. Zucchi R, Gerniway RJ, Ronca-Testoni S, Morrison RR, Ronca G, and Matherne GP (2002) Effect of cardiac A1 adenosine receptor overexpression on sarcoplasmic reticulum function. Cardiovasc Res 53:326-333.